Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Mitotane

Mixed Results for New Tx in Adrenal Cancer

Patients with advanced adrenocortical carcinoma lived no longer when standard therapy was combined with three-agent chemotherapy, but had a significantly higher response rate and progression-free survival (PFS), results of a large multicenter study showed.

Overall survival improved by almost 3 months with etoposide-doxorubicin-cisplatin (EDP) chemotherapy plus mitotane when compared with mitotane plus streptozocin, but… Mixed Results for New Tx in Adrenal Cancer   



renal cell carcinoma5 - external sphincter dyssynergia3 - autoimmune kidney disorder1 - bladder pressure4 - attention deficit hyperactivity disorder1 - urgency7 - vomiting1 - intracytoplasmic sperm injection1 - radiotherapy3 - hemolytic uremic syndrome1 - urinary tract disorder1 - clitoris3 - cystectomy1 - renal anemia1 - ectopic pregnancy2 - aggressive prostate cancer9 - recurrent incontinence1 - recurrent bladder infection1 - fluoroscopic imaging1 - progressive glomerulonephritis1 - antibiotic resistance1 - bartholin's cyst1 - labial artery1 - pomegranate juice1 - urinary calcium1 - gift1 - reduced potassium secretion1 - amgen1 - rare kidney disease1 - hemodiafiltration1 -